Search
for
Sort by
Research 121–150 of 571
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Treatment of Alopecia with New Approaches: An Updated Review
- The Efficacy of Oral Finasteride and Dutasteride in the Treatment of Female Pattern Hair Loss and Frontal Fibrosing Alopecia in Women: A Scoping Review
- 61537 No Increased Risk of Breast or Gynecologic Cancers in Women with 5α-Reductase Inhibitor Exposure for Female Pattern Hair Loss: A Population-Based Propensity Score-Matched Cohort Study
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Risk of Estrogen-Driven Malignancies in Females on 5-alpha Reductase Inhibitors
- Impact of finasteride and dutasteride in beard thickness in men with androgenetic alopecia: a 453-patient retrospective trial
- LB891 Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
- Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study
- Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques
- MP31-04 HOW DO 5-ALPHA-REDUCTASE INHIBITORS CHANGE PSA DENSITY IN PATIENTS ON ACTIVE SURVEILLANCE?
- Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- Litigation associated with 5-alpha-reductase-inhibitor use: A Canadian legal database review.
- Editor’s picks January 2021
- MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- MP09-16 5-ALPHA REDUCTASE INHIBITORS FOR MALE LOWER URINARY TRACT SYMPTOMS: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- 5α‐Reductase Inhibitors
- PD23-06 CHANGE IN SEXUAL FUNCTION IN MEN WITH LUTS/BPH ASSOCIATED WITH LONG-TERM TREATMENT WITH DOXAZOSIN, FINASTERIDE, AND COMBINED THERAPY
- Major role for 5-alpha reductase inhibitors in the aging male
- Les Visiteurs des malades
- Urological Oncology: Prostate Cancer
- Slow progress in prostate cancer
- 胃切除・腸切除術後の退院指導-パンフレットを使用して-
- Dutasteride for Androgenetic Alopecia: Review Article
- 124 The Persistent Effects of 5α-reductase Inhibitors Used in the Treatment of Androgenic Alopecia on Men’s Health